Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-29 Sale |
2022-12-01 4:16 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director |
21,959 | $16.15 | $354,638 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-05 Option Award |
2024-06-07 4:35 pm |
N/A 2034-06-04 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director |
22,213 | $0 | 31,586 (Direct) |
View |
| 2024-06-06 Exercise |
2024-06-07 4:35 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director |
4,373 | $0 | 31,586 (Direct) |
View |
| 2023-06-29 Exercise |
2023-07-03 4:15 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:21 pm |
N/A 2033-06-05 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director |
30,609 | $0 | 30,609 (Direct) |
View |
| 2023-01-18 Option Award |
2023-01-20 5:10 pm |
N/A 2033-01-18 |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
850,000 | $0 | 850,000 (Direct) |
View |
| 2023-01-13 Tax Withholding |
2023-01-17 5:36 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
5,219 | $3.17 | 319,972 (Direct) |
View |
| 2022-10-31 Other |
2023-01-17 5:36 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
1,655 | $3.2725 | 319,972 (Direct) |
View |
| 2023-01-13 Exercise |
2023-01-17 5:36 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
19,767 | $0 | 319,972 (Direct) |
View |
| 2022-11-29 Exercise |
2022-12-01 4:16 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director |
21,959 | $1.59 | 0 (Direct) |
View |
| 2022-11-29 Exercise |
2022-12-01 4:16 pm |
N/A 2025-12-15 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director |
21,959 | $0 | 0 (Direct) |
View |
| 2022-10-13 Exercise |
2022-10-17 4:38 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
19,768 | $0 | 321,881 (Direct) |
View |
| 2022-10-13 Tax Withholding |
2022-10-17 4:38 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
5,219 | $3.76 | 321,881 (Direct) |
View |
| 2022-07-13 Tax Withholding |
2022-07-15 4:57 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
5,219 | $3.01 | 328,604 (Direct) |
View |
| 2022-07-13 Exercise |
2022-07-15 4:57 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
19,768 | $0 | 328,604 (Direct) |
View |
| 2022-04-29 Other |
2022-07-15 4:57 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
1,504 | $3.842 | 328,604 (Direct) |
View |
| 2022-06-29 Option Award |
2022-06-30 4:22 pm |
N/A 2032-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-04-13 Exercise |
2022-04-15 5:05 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
19,768 | $0 | 330,815 (Direct) |
View |
| 2022-04-13 Tax Withholding |
2022-04-15 5:05 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
5,219 | $6.07 | 330,815 (Direct) |
View |
| 2022-01-13 Tax Withholding |
2022-01-14 5:08 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
5,219 | $8.3 | 336,034 (Direct) |
View |
| 2022-01-13 Exercise |
2022-01-14 5:08 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
19,768 | $0 | 336,034 (Direct) |
View |
| 2021-10-13 Tax Withholding |
2021-10-15 4:25 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
963 | $10.55 | 732,087 (Direct) |
View |
| 2021-10-13 Option Award |
2021-10-15 4:25 pm |
N/A 2031-10-13 |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
586,251 | $0 | 732,087 (Direct) |
View |
| 2021-10-13 Exercise |
2021-10-15 4:25 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
3,646 | $0 | 732,087 (Direct) |
View |
| 2021-04-30 Other |
2021-07-15 4:50 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
1,529 | $13.9 | 148,328 (Direct) |
View |
| 2021-07-13 Tax Withholding |
2021-07-15 4:50 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
963 | $13.48 | 148,328 (Direct) |
View |
| 2021-07-13 Exercise |
2021-07-15 4:50 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
3,645 | $0 | 148,328 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 4:20 pm |
N/A 2031-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director |
33,237 | $0 | 33,237 (Direct) |
View |
| 2021-01-13 Exercise |
2021-01-15 4:29 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
3,646 | $0 | 146,596 (Direct) |
View |
| 2021-01-13 Tax Withholding |
2021-01-15 4:29 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
963 | $18.16 | 146,596 (Direct) |
View |
| 2020-04-30 Other |
2020-10-15 4:23 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
1,158 | $12.12 | 498,717 (Direct) |
View |
| 2020-10-13 Option Award |
2020-10-15 4:23 pm |
N/A 2030-10-13 |
HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer |
408,333 | $0 | 498,717 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-02 4:12 pm |
N/A 2030-06-29 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director |
18,760 | $0 | 18,760 (Direct) |
View |